This work highlights the therapeutic potential of targeting EEF1A1 in the setting of MASLD and the utility of RNA-Seq deconvolution to reveal valuable information about tissue cell type composition and cell type-associated gene expression from bulk RNA-Seq data. Here, EEF1A1 is linked to metabolic dysfunction-associated steatotic liver disease.